Advances in Mitochondria-Targeted Drug Delivery

Dear Colleagues,

Mitochondria are dynamic organelles considered the cell’s powerhouses, converting energy stored in nutrients into ATP through the oxidative phosphorylation system. Mitochondria also play a pivotal role in other functions, such as heme biosynthesis, oxygen sensing, calcium homeostasis, and cell growth, fate, and death.

Whether primary or secondary, mitochondrial dysfunctions are increasingly recognized as a hallmark of several pathologies, including cancer, neurological, cardiovascular, immunological, and metabolic disorders; therefore, growing efforts are directed toward mitochondria as a therapeutic target.

This Special Issue aims to collect the current state of the art on therapeutic advances in mitochondrial medicine, approaches for mitochondrial-targeted drug delivery, and metabolic and gene therapy strategies.

Original research articles, comprehensive reviews, and short communications that will supply important novel data are welcome.

We look forward to receiving your contributions.

Dr. Dario Brunetti
Dr. Emanuela Bottani
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.